FibroGen, Inc.

FibroGen, Inc.verified

FGEN

Price:

$9.07

Market Cap:

$28.86M

FibroGen, Inc. is a biopharmaceutical firm dedicated to discovering, developing, and bringing to market therapies that address significant medical conditions currently lacking effective treatments. Among its pipeline, FibroGen is advancing Roxadustat, an orally administered small molecule that inhibits hypoxia inducible factor prolyl hydroxylases. This drug has successfully completed Phase III clinical trials in the US, Europe, China, and Japan for treating anemia in chronic kidney disease, and is currently in Phase II/III development in China for anemia linked to myelodysplastic syndromes. Additionally, the company is progressing Pamrevlumab, a human monoclonal antibody designed to block co...[Read more]

Industry

Biotechnology

IPO Date

2014-11-14

Stock Exchange

NASDAQ

Ticker

FGEN

The Enterprise Value as of June 2026 (TTM) for FibroGen, Inc. (FGEN) is 11.12M

According to FibroGen, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 11.12M. This represents a change of 104.80% compared to the average of 5.43M of the last 4 quarters.

FibroGen, Inc. (FGEN) Historical Enterprise Value (quarterly & annually)

How has FGEN Enterprise Value performed in the past?

The mean historical Enterprise Value of FibroGen, Inc. over the last ten years is 46.57B. The current 11.12M Enterprise Value has changed -97.61% with respect to the historical average. Over the past ten years (40 quarters), FGEN's Enterprise Value was at its highest in in the June 2018 quarter at 130.36B. The Enterprise Value was at its lowest in in the September 2025 quarter at -47396000.00.

Quarterly (TTM)
Annual

Average

46.57B

Median

35.45B

Minimum

73.17M

Maximum

97.27B

FibroGen, Inc. (FGEN) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of FibroGen, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 156.52%

Maximum Annual Enterprise Value = 97.27B

Minimum Annual Increase = -94.64%

Minimum Annual Enterprise Value = 73.17M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202573.17M-94.64%
20241.36B-38.35%
20232.21B-94.09%
202237.41B15.18%
202132.48B-60.71%
202082.68B-10.92%
201992.82B-4.57%
201897.27B13.22%
201785.91B156.52%
201633.49B-27.04%

FibroGen, Inc. (FGEN) Average Enterprise Value

How has FGEN Enterprise Value performed in the past?

The current Enterprise Value of FibroGen, Inc. (FGEN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

1.22B

5-year avg

14.71B

10-year avg

46.57B

FibroGen, Inc. (FGEN) Enterprise Value vs. Peers

How is FGEN’s Enterprise Value compared to its peers?

FibroGen, Inc.’s Enterprise Value is greater than Kezar Life Sciences, Inc. (-11018667.00), less than Tempest Therapeutics, Inc. (11.64M), greater than Aligos Therapeutics, Inc. (6.87M), greater than OnKure Therapeutics, Inc. (-134267880.00), less than Mersana Therapeutics, Inc. (91.27M), less than X4 Pharmaceuticals, Inc. (161.10M), less than PDS Biotechnology Corporation (52.81M), less than Celularity Inc. (51.87M), greater than Xilio Therapeutics, Inc. (-89055595.00), greater than Actinium Pharmaceuticals, Inc. (-8924256.00),

Build a custom stock screener for FibroGen, Inc. (FGEN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like FibroGen, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

FibroGen, Inc. (FGEN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like FibroGen, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is FibroGen, Inc.'s Enterprise Value?

What is the highest Enterprise Value for FibroGen, Inc. (FGEN)?

What is the 3-year average Enterprise Value for FibroGen, Inc. (FGEN)?

What is the 5-year average Enterprise Value for FibroGen, Inc. (FGEN)?

How does the current Enterprise Value for FibroGen, Inc. (FGEN) compare to its historical average?